Acute Coronary Syndrome News and Research

RSS
Study proposes an integrative dynamic model of depression-CAD relationship

Study proposes an integrative dynamic model of depression-CAD relationship

HRPR before PCI procedures linked to increased risk of ischemic event in ACS patients

HRPR before PCI procedures linked to increased risk of ischemic event in ACS patients

Combination of prasugrel plus ASA can treat acute coronary syndrome

Combination of prasugrel plus ASA can treat acute coronary syndrome

Miracor closes first round of Series B financing

Miracor closes first round of Series B financing

Reduction in smoking has positive impact on mortality rates within six months

Reduction in smoking has positive impact on mortality rates within six months

AstraZeneca: BRILIQUE receives Class I recommendation from ESC

AstraZeneca: BRILIQUE receives Class I recommendation from ESC

Results of darexaban phase II trial in recent acute coronary syndrome presented at ESC Congress

Results of darexaban phase II trial in recent acute coronary syndrome presented at ESC Congress

Intra-aortic balloon counterpulsation prior to PCI does not reduce infarct size in AMI patients

Intra-aortic balloon counterpulsation prior to PCI does not reduce infarct size in AMI patients

Dabigatran etexilate superior to warfarin for stroke prevention in AF patients

Dabigatran etexilate superior to warfarin for stroke prevention in AF patients

Pericardial fat linked with coronary arterial remodeling, non calcified plaque related to ACS

Pericardial fat linked with coronary arterial remodeling, non calcified plaque related to ACS

AstraZeneca announces availability of BRILINTA tablets in the U.S. pharmacies

AstraZeneca announces availability of BRILINTA tablets in the U.S. pharmacies

Coronary stent implantation safe, feasible for infants or toddlers with ACS

Coronary stent implantation safe, feasible for infants or toddlers with ACS

Enrollment commences in St. Jude Medical's atrial fibrillation stroke prevention trial

Enrollment commences in St. Jude Medical's atrial fibrillation stroke prevention trial

Spiritual retreat can help heart patients return to psycho-spiritual well-being

Spiritual retreat can help heart patients return to psycho-spiritual well-being

Anthera reports increase in second quarter total operating expenses to $22.7 million

Anthera reports increase in second quarter total operating expenses to $22.7 million

Takeda resubmits alogliptin and fixed-dose combination therapy NDA to FDA

Takeda resubmits alogliptin and fixed-dose combination therapy NDA to FDA

FDA approves Brilinta to reduce cardiovascular death and heart attack in ACS patients

FDA approves Brilinta to reduce cardiovascular death and heart attack in ACS patients

AstraZeneca receives FDA approval for BRILINTA to treat acute coronary syndrome

AstraZeneca receives FDA approval for BRILINTA to treat acute coronary syndrome

FDA approves AstraZeneca's anti-clotting drug Brilinta

FDA approves AstraZeneca's anti-clotting drug Brilinta

ThromboView gets positive results in study evaluating accuracy and safety

ThromboView gets positive results in study evaluating accuracy and safety

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.